GQDs have typical dimensions of up to a few nanometers and circular or elliptical shapes (Yang et al., 2015)
Jank L, Tth E, Laczik M, Rauch B, Janka E, Blint BL, et al
Zhang Z, Wu Y, Yuan S, Zhang P, Zhang J, Li H, et al
In conclusion, T1DM patients have absent insulin levels in the portal vein, which makes their liver very GH-resistant
In this article, well compound that discussion (no pun intended) a bit more by looking forward at the IP landscape - something that will become increasingly important
[1] [9] Retatrutide is an investigational triple receptor agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors